Curr Sex Health Rep (2017) 9:290–295 https://doi.org/10.1007/s11930-017-0135-0 MEDICAL COMORBIDITIES (M MINER, S PARISH AND A GOLDSTEIN, SECTION EDITORS) The Testosterone Trials: What the Results Mean for Healthcare Providers and for Science Abraham Morgentaler Published online: 2 November 2017 Springer Science+Business Media, LLC 2017 Abstract Introduction Purpose of Review The purpose of this review was to assess the results of the Testosterone (T) Trials with regard to their The primary results of the Testosterone (T) Trials were pub- clinical and scientific implications. lished in the New England Journal of Medicine in February Recent Findings The T Trials investigated 1 year of T gel 2016 [1 ], followed by several subsequent reports for various versus placebo in 790 men 65 years and older with unequiv- individual component Trials [2–4, 5� ]. These results had been ocally low serum T concentrations (< 275 ng/dl). Safety mon- long anticipated, as until this study there had been no large itoring was performed for an additional year. Primary results controlled prospective study investigating testosterone in were improvement over placebo for sexual desire, sexual ac- men, leaving open questions about efficacy and safety that tivity, erection quality, physical activity, and mood. Vitality could not be answered
Current Sexual Health Reports – Springer Journals
Published: Nov 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera